1. Enasidenib (AG-221), A Selective Oral Inhibitor of Mutant Isocitrate Dehydrogenase 2 (IDH2) Enzyme, In Patients with Myelodysplastic Syndromes (MDS). (April 2017) Authors: Stein, E.M.; Fathi, A.T.; DiNardo, C.D.; Pollyea, D.A.; Swords, R.T.; Roboz, G.J.; Collins, R.; Sekeres, M.A.; Stone, R.M.; Attar, E.C.; Tosolini, A.; Xu, Q.; Amatangelo, M.; Gupta, I.; Knight, R.D.; de Botton, S.; Tallman, M.S.; Kantarjian, H.M. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S24 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P940: SAFETY AND CLINICAL ACTIVITY OF BELANTAMAB MAFODOTIN WITH PEMBROLIZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): DREAMM-4 STUDY. (23rd June 2022) Authors: Suvannasankha, A.; Bahlis, N.; Trudel, S.; Weisel, K.; Koenecke, C.; Oriol, A.; Voorhees, P. M.; Alonso, A. A.; Callander, N. S.; Mateos Manteca, M. V.; Reddy, N.; Hakim, S.; Patel, N.; Williams, D.; Jewell, R. C.; Zhou, X.; Gupta, I.; Nooka, A. K. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 830 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P941: SAFETY AND CLINICAL ACTIVITY OF BELANTAMAB MAFODOTIN WITH LENALIDOMIDE PLUS DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): DREAMM-6 ARM-A INTERIM ANALYSIS. (23rd June 2022) Authors: Quach, H.; Gironella, M.; Lee, C.; Popat, R.; Cannell, P.; Kasinathan, R. S.; Chopra, B.; Rogers, R.; Ferron-Brady, G.; Shafi-Harji, S.; Patel, N.; Opalinska, J.; Gupta, I.; Augustson, B. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 831 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Groundwater age, brine migration, and large‐scale solute transport in the Alberta Basin, Canada. Issue 4 (6th March 2015) Authors: Gupta, I.; Wilson, A. M.; Rostron, B. J. Journal: Geofluids Issue: Volume 15:Issue 4(2015:Nov.) Page Start: 608 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Rpb4 and Puf3 imprint and post-transcriptionally control the stability of a common set of mRNAs in yeast. Issue 8 (3rd August 2021) Authors: Garrido-Godino, A.I.; Gupta, I.; Gutiérrez-Santiago, F; Martínez-Padilla, A.B.; Alekseenko, A.; Steinmetz, L.M.; Pérez-Ortín, J.E.; Pelechano, V.; Navarro, F. Journal: RNA biology Issue: Volume 18:Issue 8(2021) Page Start: 1206 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P233 CD146/Akt/NF-κB/latexin is a novel pathway involved in suppressing breast tumor growth. (March 2015) Authors: Ouhtit, A.; Fernando, A.; Elmageed, Z. Abd; Gupta, I.; Shanmuganathan, S. Journal: Breast Issue: Volume 24(2015)Supplement 1 Page Start: S105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P234 BRIP-1, a novel marker of breast tumor malignancy in the Omani population. (March 2015) Authors: Gupta, I.; Ouhtit, A.; Riyami, M. Al; Ajmi, A. Al Journal: Breast Issue: Volume 24(2015)Supplement 1 Page Start: S105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Meticillin-resistant Staphylococcus aureus and meticillin-susceptible Staphylococcus aureus screening in a cohort of haemodialysis patients: carriage, demographics and outcomes. Issue 1 (May 2015) Authors: Price, A.; Sarween, N.; Gupta, I.; Baharani, J. Journal: Journal of hospital infection Issue: Volume 90:Issue 1(2015) Page Start: 22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗